Voorbeelden van het gebruik van Continued therapy in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
She will need continued therapy in Iraq.
Continued therapy has been associated with hepatic coma and death.
What are the opportunities for continued therapy& supervision for therapists?
With continued therapy, responses were maintained up to 48 weeks.
Prescribers are advised to periodically reassess the need for continued therapy.
Patients continued therapy until disease progression or unacceptable toxicity.
In these patients, the majority of lymphocyte counts remained< 0.5 x 109/L with continued therapy.
If continued therapy is indicated,
Rash was mostly self-limiting and generally resolved within 1 to 2 weeks on continued therapy.
Continued therapy should be carefully considered in a subject not responding by Week 12.
The rash associated with the efavirenz component usually resolves with continued therapy.
Continued therapy should be carefully reconsidered in a patient not responding within this time period.
altogether 188 patients continued therapy.
Continued therapy should be carefully reconsidered in a patient exhibiting no improvement within this timeframe.
The patient' s response to treatment and need for continued therapy should be re-evaluated on a regular basis.
Continued therapy should be carefully reconsidered in a patient not responding within this time period.
usually resolves with continued therapy.
After 2 years continued therapy should be considered only following a reassessment of the potential for benefit and risk.
the risk versus benefit of continued therapy with Pixuvri must be evaluated.
Patients continued therapy until disease progression
disappears spontaneously on continued therapy, and has not been shown to be predictive of acute
Continued therapy beyond 12 weeks should be carefully reconsidered in a patient with no improvement within this time period.
these common symptoms are likely to improve with continued therapy and are not predictive of subsequent onset of any of the less frequent psychiatric symptoms.
Continued therapy beyond this time should be considered only following a reassessment of the potential for benefit and risk.
the benefit of continued therapy must be carefully weighed against the risk of myocardial injury.
Continued therapy should be reconsidered in patients who show no evidence of therapeutic benefit within this time period.
the benefit of continued therapy with efavirenz needs to be weighed against the potential risks of significant liver toxicity.
Continued therapy should be carefully reconsidered in patients who show no evidence of therapeutic benefit after dose adjustment.
The benefits of long-term virologic suppression with continued therapy must be weighed against the risk of prolonged treatment,
Continued therapy must be carefully reconsidered in patients who show no evidence of therapeutic benefit beyond 6 months.